FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> United Kingdom | swine flu

U.K. tallies losses on pandemic vaccine

Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!

  • Subscribe
  • Email
  • Print
  • Contact Author
  • Reprint

U.K. officials say they essentially lost more than £200 million ($308.9 million) buying up excess quantities of swine flu vaccine and antiviral meds. About a third of that loss occurred because unused vaccines weren't stored properly. And there's no secondary market for their surplus. "The worldwide surplus of swine flu vaccine means that there is no active market in which the department's excess pandemic flu inventory can be sold," health officials report. Story

Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceVaccines Email Newsletter:

More stories about United Kingdom   swine flu